Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Rua Bioscience Ltd. ( (NZ:RUA) ) just unveiled an update.
Rua Bioscience has issued 1.4 million new ordinary shares at zero cash cost as part of a long-term incentive plan for its chief executive officer, under an agreement with the board and relevant listing rules. The options carry a nil issue and exercise price and convert into fully paid ordinary shares ranking equally with existing stock, increasing total shares on issue to 339,441,705 and representing about 0.41% of the company’s fully diluted share capital, including warrants.
More about Rua Bioscience Ltd.
Rua Bioscience Limited is a New Zealand-based pharmaceutical company listed on the NZX under ticker RUA. The company issues ordinary shares and warrants and is focused on building long-term value through equity-based incentives for key executives, including its chief executive officer.
Average Trading Volume: 44,008
Technical Sentiment Signal: Sell
Current Market Cap: N$9.8M
See more data about RUA stock on TipRanks’ Stock Analysis page.